Effects of Gong's Mobilization With and Without Scapular High Lift on Shoulder Range of Motion and Functional Recovery in Adhesive Capsulitis. (Gongs Mob)

December 22, 2025 updated by: Danyal Ahmad, University of Management and Technology Sialkot Pakistan

Effects of Gong's Mobilization With and Without Scapular High Lift on Shoulder Range of Motion and Functional Recovery in Adhesive Capsulitis; a Randomized Clinical Trial

This study aims to compare the effectiveness of Gongs Mobilization with and without scapular High-lift in the management of Adhesive Capsulitis, focusing on specific outcomes like pain, functional outcomes, and work productivity.

Study Overview

Detailed Description

This study will be a randomized controlled trial with a sample size of 42 participants, as calculated by the G power tool, with 5 % attrition rate, diagnosed with Adhesive Capsulitis. Subjects will be selected through non-probability convenient sampling based on inclusion and exclusion criteria, and randomly assigned into two groups, with 21 participants in each group. Group A will receive Gong mobilization with scapular high-lift, while Group B will receive Gong mobilization without scapular high-lift, both in conjunction with conventional therapy. Demographic Data will also be collected. Baseline and post-intervention data will be collected using SPADI, NPRS, and a goniometer. Data will be analyzed by using IBM SPSS 26.0. At the same time, the Shapiro-Wilk test will be applied to check normality.

Study Type

Interventional

Enrollment (Estimated)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab Province
      • Sialkot, Punjab Province, Pakistan, 51040
        • Bethania Hospital Sialkot
      • Sialkot, Punjab Province, Pakistan, 51310
        • Raheem Surgical Hospital Sambrial
      • Sialkot, Punjab Province, Pakistan, 51310
        • University of Management and technology Sialkot Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Participants, including both males and females.
  • aged 40 to 60 years.
  • Diagnosed with unilateral Adhesive capsulitis at the 2nd or 3rd stage of the disease

Exclusion Criteria:

  • History of any trauma, tumor, fracture, surgery, or infection in a shoulder joint.
  • Patient with pregnancy and a history of abnormal neurological status (radiculopathy, stroke with hemiplegia, brachial plexus injury).
  • Restricted shoulder due to burns or postoperative scars.
  • Moderate or High levels of diabetes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: GROUP A (GONG'S MOBILIZATION WITH SCAPULAR HIGHLIFTS)
GROUP A (GONG'S MOBILIZATION WITH SCAPULAR HIGHLIFTS) containing 21 participants who will be given Gong's mobilization with scapular high lifts for 30 minutes along with the conventional physiotherapy.
In this technique, the therapist applies a sustained lateral glide to the humeral head while the patient actively performs shoulder elevation or abduction. Scapular high lifting is encouraged during the movement to assist shoulder elevation. The technique is performed within a pain-free range to reduce pain and improve shoulder mobility and functional movement.
Experimental: GROUP B (GONG'S MOBILIZATION WITHOUT SCAPULAR HIGHLIFTS)
GROUP B (GONG'S MOBILIZATION WITHOUT SCAPULAR HIGHLIFTS) containing 21 participants who were given Gong's mobilization without scapular high lifts for 30 minutes along with the conventional physiotherapy
Patients received Gong's mobilization without allowing scapular high lifting. The therapist applied a lateral glide to the humeral head while the patient performed pain-free shoulder elevation or abduction. Scapular movement was controlled to avoid compensation, aiming to reduce pain and improve shoulder mobility and function.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NUMERICAL PAIN RATING SCALE (NPRS)
Time Frame: 4 Weeks
It is a fundamental tool used to evaluate pain intensity and pain tolerance. Subjects can rate their pain from 0 (no pain at all) to 10 (pain as bad as it could be) to check whether the pain is acute or chronic. 42. The test-retest reliability coefficient, the intra-class correlation coefficient (ICC) for NPRS, is 0.74, and the minimal clinically important difference (MCID) is 1.1 points
4 Weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SHOULDER PAIN AND DISABILITY INDEX (SPADI)
Time Frame: 4 Weeks
SPADI is used to assess shoulder discomfort and impairment in patients with shoulder disorders. It consists of 13 items divided into two domains; a sub-scale that measures pain contains 5 items, and the other sub-scale consists of 8 items to assess disability. Every sub-scale has a scoring method that calculates the average (mean) at the end to make a score out of 100. A high score indicates greater impairment or disability, and vice versa. The reliability coefficient, the intra-class correlation, is ≥ 0.89, and its minimal clinically important difference (MCID) is 8 points
4 Weeks
UNIVERSAL GONIOMETERY:
Time Frame: 4 Weeks
The primary movements of the shoulder include flexion and extension, abduction and adduction, horizontal abduction and adduction, as well as lateral and medial rotation. While these movements are assessed at the glenohumeral joint, they rely on coordinated mobility at the sternoclavicular, acromioclavicular, and scapulothoracic joints41. For shoulder AROM, the reliability coefficient, intra-class correlation (ICC), is 0.53-0.6544. The ICC for PROM ranges from 0.87 to 0.99
4 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: HAMZA ZAHID, MS OMPT, University of Management and Technology Sialkot Pakistan

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2026

Primary Completion (Estimated)

March 30, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

December 22, 2025

First Submitted That Met QC Criteria

December 22, 2025

First Posted (Actual)

January 7, 2026

Study Record Updates

Last Update Posted (Actual)

January 7, 2026

Last Update Submitted That Met QC Criteria

December 22, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • kuhs/dpt/umt-skt-027

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

IPD may not be shared due to concerns regarding patient confidentiality, data ownership, ethical approvals, and consent limitations, as well as institutional or legal restrictions. Additionally, data may be withheld to protect ongoing analyses or unpublished results, or because the data contain sensitive information that cannot be fully anonymized.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adhesive Capsulitis

Clinical Trials on Experimental: GROUP A (GONG'S MOBILIZATION WITH SCAPULAR HIGHLIFTS)

Subscribe